Delee is a medical device company that has developed two devices: the CytoCatch™ Isolation Platform and the CytoCatch™ Imaging System, for isolating and analyzing circulating tumor cells (CTCs) from patient blood samples. The isolation platform filters CTCs onto a membrane and stains them through an automated workflow for visualization, and analysis via the imaging system. This technology will help in the early detection of cancer while providing physicians with information to personalize each patient’s therapy and monitor its effectiveness throughout the course of their disease.
| Website | https://www.delee.co/ |
| Employees | 11 (7 on RocketReach) |
| Founded | 2017 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+15 more
(view full list)
|
| Industry | Biotechnology Research, Health Care, Health Diagnostics, Personal Health |
| Keywords | Circulating Tumor Cells, Medical Devices, Liquid Biopsy, Cancer Diagnostics, Precision Oncology, Tumor Detection, Oncology Diagnostics, Cell Isolation, Biomedical Engineering, Diagnostic Tools, Medical Technology, Healthcare Technology, Cancer Research, In Vitro Diagnostics, Medical Imaging, Disease Diagnostics, Biotechnology |
| Competitors | Stryker, 3M, Cardinal Health, Medline Industries, LP, Baxter International Inc., Hollister Incorporated, Smiths Medical, Fisher & Paykel Healthcare, Convatec Brasil, Halyard Health +42 more (view full list) |
Looking for a particular Delee Corp employee's phone or email?
Juan Yee is the Co-Founder, CMO, and Director of Delee Corp.
7 people are employed at Delee Corp.